252 related articles for article (PubMed ID: 24817689)
1. MicroRNA expression signatures and their correlation with clinicopathological features in glioblastoma multiforme.
Henriksen M; Johnsen KB; Olesen P; Pilgaard L; Duroux M
Neuromolecular Med; 2014 Sep; 16(3):565-77. PubMed ID: 24817689
[TBL] [Abstract][Full Text] [Related]
2. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L
Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456
[TBL] [Abstract][Full Text] [Related]
3. Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures.
Yerukala Sathipati S; Huang HL; Ho SY
BMC Genomics; 2016 Dec; 17(Suppl 13):1022. PubMed ID: 28155650
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous miRNA and mRNA transcriptome profiling of glioblastoma samples reveals a novel set of OncomiR candidates and their target genes.
Gulluoglu S; Tuysuz EC; Sahin M; Kuskucu A; Kaan Yaltirik C; Ture U; Kucukkaraduman B; Akbar MW; Gure AO; Bayrak OF; Dalan AB
Brain Res; 2018 Dec; 1700():199-210. PubMed ID: 30176243
[TBL] [Abstract][Full Text] [Related]
5. Long non‑coding RNA Unigene56159 promotes glioblastoma multiforme cell proliferation and invasion through negatively regulating microRNA‑194‑5p.
Jiang G; Dong H; Dong Y; Yang X
Mol Med Rep; 2020 Feb; 21(2):768-776. PubMed ID: 31789416
[TBL] [Abstract][Full Text] [Related]
6. Functional differences of miR-125b on the invasion of primary glioblastoma CD133-negative cells and CD133-positive cells.
Shi L; Wan Y; Sun G; Gu X; Qian C; Yan W; Zhang S; Pan T; Wang Z; You Y
Neuromolecular Med; 2012 Dec; 14(4):303-16. PubMed ID: 22711523
[TBL] [Abstract][Full Text] [Related]
7. MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response.
Besse A; Sana J; Lakomy R; Kren L; Fadrus P; Smrcka M; Hermanova M; Jancalek R; Reguli S; Lipina R; Svoboda M; Slampa P; Slaby O
Tumour Biol; 2016 Jun; 37(6):7719-27. PubMed ID: 26692101
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion.
Møller HG; Rasmussen AP; Andersen HH; Johnsen KB; Henriksen M; Duroux M
Mol Neurobiol; 2013 Feb; 47(1):131-44. PubMed ID: 23054677
[TBL] [Abstract][Full Text] [Related]
9. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
[TBL] [Abstract][Full Text] [Related]
10. A 4-miRNAs signature predicts survival in glioblastoma multiforme patients.
Yuan GQ; Wei NL; Mu LY; Wang XQ; Zhang YN; Zhou WN; Pan YW
Cancer Biomark; 2017 Dec; 20(4):443-452. PubMed ID: 28869437
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of PDGFRB and EGFR in microvascular proliferation in glioblastoma.
Xu G; Li JY
Tumour Biol; 2016 Aug; 37(8):10577-86. PubMed ID: 26857280
[TBL] [Abstract][Full Text] [Related]
12. Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme.
Yan W; Zhang W; Sun L; Liu Y; You G; Wang Y; Kang C; You Y; Jiang T
Brain Res; 2011 Sep; 1411():108-15. PubMed ID: 21831363
[TBL] [Abstract][Full Text] [Related]
13. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
14. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
Chen X; Pan Y; Yan M; Bao G; Sun X
Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
[TBL] [Abstract][Full Text] [Related]
15. Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma.
Yu W; Liang S; Zhang C
Neuromolecular Med; 2018 Dec; 20(4):452-474. PubMed ID: 30182330
[TBL] [Abstract][Full Text] [Related]
16. A robust two-gene signature for glioblastoma survival prediction.
Pan Y; Zhang JH; Zhao L; Guo JC; Wang S; Zhao Y; Tao S; Wang H; Zhu YB
J Cell Biochem; 2020 Jul; 121(7):3593-3605. PubMed ID: 31960992
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview.
Henriksen M; Johnsen KB; Andersen HH; Pilgaard L; Duroux M
Mol Neurobiol; 2014 Dec; 50(3):896-913. PubMed ID: 24619503
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy.
Park EC; Kim G; Jung J; Wang K; Lee S; Jeon SS; Lee ZW; Kim SI; Kim S; Oh YT; Shin JH; Jang HS; Choi BO; Kim GH
OMICS; 2013 May; 17(5):259-68. PubMed ID: 23586679
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-125b down-regulates matrix metallopeptidase 13 and inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion.
Xu N; Zhang L; Meisgen F; Harada M; Heilborn J; Homey B; Grandér D; Ståhle M; Sonkoly E; Pivarcsi A
J Biol Chem; 2012 Aug; 287(35):29899-908. PubMed ID: 22782903
[TBL] [Abstract][Full Text] [Related]
20. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]